Welcome to our dedicated page for HEALTHPEAK PROPERTIES SEC filings (Ticker: DOC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Healthpeak Properties, Inc. filings document the regulatory record of a Maryland REIT focused on healthcare discovery and delivery real estate. Form 8-K reports furnish quarterly and annual financial results, supplemental operating information, Regulation FD materials, non-GAAP reconciliations, and material agreements tied to credit facilities and other financing activity.
Proxy and annual-meeting filings describe board elections, shareholder voting results, executive compensation, and governance matters. The filing record also covers capital-structure disclosures for Healthpeak and Healthpeak OP, including unsecured term loan amendments, delayed-draw financing, senior notes, and related subsidiary financing activity.
Healthpeak Properties, Inc. reported an insider share purchase by its Chief Financial Officer. On 11/28/2025, the CFO acquired 810 shares of common stock at $14.7985 per share through the company’s Employee Stock Purchase Plan, which allows employees to buy stock via payroll contributions.
On the same date, 55 shares were forfeited at a value of $18.26 per share to cover tax withholding obligations tied to this purchase, a transaction that is explicitly described as not constituting a sale. After these transactions, the CFO beneficially owned 755 shares of Healthpeak Properties common stock in direct form.
Healthpeak Properties, Inc. president and CEO (also a director) reported routine stock transactions on Form 4. On 11/28/2025, the executive acquired 1,689 shares of common stock through the company’s Employee Stock Purchase Plan at a price of $14.7985 per share. On the same date, 140 shares were forfeited at a value of $18.26 per share to cover tax withholding obligations tied to the ESPP purchase, which is described as not constituting a sale transaction. After these transactions, the executive directly beneficially owns 213,455 shares of Healthpeak Properties common stock.
Healthpeak Properties (DOC) reported Q3 results showing steady top-line performance but a bottom-line swing to a loss. Total revenues were $705.9 million, up slightly year over year, as rental and related revenues held near prior levels and resident fees and services rose. Costs and expenses declined modestly, helped by lower depreciation and general and administrative expense.
The quarter’s net loss was $117.1 million (basic and diluted EPS $(0.17)) versus income a year ago, primarily driven by $176.3 million of equity loss from unconsolidated joint ventures. Interest expense rose modestly to $76.8 million. Gains on real estate sales were $11.5 million. For the first nine months, revenues reached $2.10 billion and net loss attributable to the company was $42.6 million.
On the balance sheet, total assets were $19.6 billion and total liabilities $11.3 billion. Cash and cash equivalents were $91.0 million, with bank line and commercial paper borrowings at $368.1 million and senior unsecured notes at $6.77 billion. Operating cash flow for the nine months was $957.9 million, supporting ongoing development and capital programs. Shares outstanding were 694,949,823 as of October 22, 2025.
Healthpeak Properties, Inc. (DOC) filed a Form 8-K announcing it furnished its financial results for the three and nine months ended September 30, 2025. The company issued a press release and provided a supplemental report and a discussion and reconciliation of non-GAAP financial measures.
The materials are available on the Investor Relations website and were furnished as Exhibits 99.1 (press release), 99.2 (supplemental report), and 99.3 (non-GAAP reconciliation). The information in Items 2.02 and 7.01 and the related exhibits was furnished, not filed, under the Exchange Act.
Healthpeak Properties, Inc. filed an 8-K that includes exhibit disclosures related to debt and legal opinions. The filing attaches the form of 4.750% Senior Notes due 2033 as Exhibit 4.1, legal opinions from Ballard Spahr LLP and Latham & Watkins LLP as Exhibits 5.1 and 5.2, and their consents included with those opinions as Exhibits 23.1 and 23.2. The document also references the Interactive Data Cover Page File and identifies Kelvin O. Moses as Chief Financial Officer for the registrant. Basic listing details such as Common Stock, $1.00 par value, and the New York Stock Exchange appear on the cover page.
Healthpeak Properties, Inc. (NYSE: DOC) filed an 8-K to report an administrative update to its February 5, 2025 shelf registration on Form S-3. Exhibit 99.1—titled “United States Federal Income Tax Considerations”—is being added and expressly supersedes the tax discussion contained in the original prospectus that forms part of the registration statement (File Nos. 333-276954-00 through -03). No new securities are being registered, and the filing does not include operating results, guidance, or transaction details. The purpose is to ensure that future securities offerings made under the shelf reflect the most current federal income tax analysis applicable to investors in the company’s REIT structure. The report was signed by CFO Kelvin O. Moses on August 5, 2025.
Healthpeak Properties (DOC) Form 4: President & CEO Scott M. Brinker purchased 1,490 common shares on 08/04/2025 at $16.83, an outlay of roughly $25k. Post-transaction direct ownership rises to 211,906 shares. No derivative trades were reported. The filing reflects routine insider buying and does not alter control status; Brinker remains both a director and executive officer.
Healthpeak Properties (DOC) – Form 4 insider activity
On 07/31/2025, President & CEO Scott M. Brinker made an open-market purchase (Code “P”) of 2,930 shares of common stock at $17.06 each. Following the trade, his direct ownership rose to 210,416 shares; no indirect or derivative holdings were reported.
The filing involves only one transaction, no 10b5-1 plan disclosure and no amendments. While insider buying can signal management’s confidence, the dollar value (≈$50k) and <≈0.04 % of the ≈539 m shares outstanding render the move modestly incremental.